| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.91B | $1.87B | $1.82B |
| YoY Revenue Growth % | +2.0% | +2.7% | — |
| Gross Profit | $455.6M | $432.3M | — |
| Gross Margin % | 23.9% | 23.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $220.3M | $199.4M | $141.5M |
| Operating Margin % | 11.5% | 10.7% | 7.8% |
| Net Income (GAAP) | $167.3M | $158.6M | $111.3M |
| EBITDA (Normalized) | $266.7M | $253.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $261.5M | $251.6M | $225.9M |
| Capital Expenditures (CapEx) | $58.0M | $67.6M | — |
| Free Cash Flow (FCF) | $203.5M | $184.0M | $225.9M |
| FCF Margin % | 10.7% | 9.8% | 12.4% |
| Return on Invested Capital (ROIC %) | 20.9% | 20.3% | — |
| Cash & Short-Term Equivalents | $201.6M | $203.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.03B | $979.9M | — |